Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.
Huber V, Di Guardo L, Lalli L, Giardiello D, Cova A, Squarcina P, Frati P, Di Giacomo AM, Pilla L, Tazzari M, Camisaschi C, Arienti F, Castelli C, Rodolfo M, Beretta V, Di Nicola M, Maio M, Del Vecchio M, de Braud F, Mariani L, Rivoltini L. Huber V, et al. Among authors: mariani l. J Immunother Cancer. 2021 Feb;9(2):e001167. doi: 10.1136/jitc-2020-001167. J Immunother Cancer. 2021. PMID: 33589521 Free PMC article.
Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells.
Perego M, Tortoreto M, Tragni G, Mariani L, Deho P, Carbone A, Santinami M, Patuzzo R, Mina PD, Villa A, Pratesi G, Cossa G, Perego P, Daidone MG, Alison MR, Parmiani G, Rivoltini L, Castelli C. Perego M, et al. Among authors: mariani l. J Invest Dermatol. 2010 Jul;130(7):1877-86. doi: 10.1038/jid.2010.69. Epub 2010 Apr 8. J Invest Dermatol. 2010. PMID: 20376064 Free article.
Spheres of influence in cancer stem cell biology.
Perego M, Alison MR, Mariani L, Rivoltini L, Castelli C. Perego M, et al. Among authors: mariani l. J Invest Dermatol. 2011 Feb;131(2):546-7. doi: 10.1038/jid.2010.305. Epub 2010 Oct 21. J Invest Dermatol. 2011. PMID: 20962857 Free article. No abstract available.
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
Guidetti A, Carlo-Stella C, Ruella M, Miceli R, Devizzi L, Locatelli SL, Giacomini A, Testi A, Buttiglieri S, Risso A, Mariani L, Di Nicola M, Passera R, Tarella C, Gianni AM. Guidetti A, et al. Among authors: mariani l. Cancer. 2011 Nov 15;117(22):5074-84. doi: 10.1002/cncr.26182. Epub 2011 May 12. Cancer. 2011. PMID: 21567384 Free article. Clinical Trial.
1,156 results